paxalisib

Advertisement

cGxPJobs Banner

Paxalisib Boosts Anti-Tumor Immunity in Advanced Breast Cancer

SYDNEY, Dec. 10, 2025 — Kazia Therapeutics Limited (NASDAQ: KZIA) unveiled compelling clinical and translational data highlighting the ability...

By cGxPwire Editor
December 11, 2025

Read More

Kazia Therapeutics Secures $50M Private Placement to Strengthen Pipeline Funding

Sydney, Australia, December 3, 2025 — Kazia Therapeutics has announced the pricing of a US $50 million private placement...

By cGxPwire Editor
December 3, 2025

Read More

Advertisement

cGxPJobs

Directory